467
Views
17
CrossRef citations to date
0
Altmetric
Review

Influences of environmental exposures on individuals living with cystic fibrosis

, , , , , , , , , , & show all
Pages 737-748 | Received 09 Jan 2020, Accepted 06 Apr 2020, Published online: 26 Apr 2020

References

  • Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet. 2014;383(9928):1581–1592.
  • Mirabelli MC, Vaidyanathan A, Flanders WD, et al. Outdoor PM2.5, ambient air temperature, and asthma symptoms in the past 14 days among adults with active asthma. Environ Health Perspect. 2016;124(12):1882–1890.
  • Hansel NN, McCormack MC, Kim V. The effects of air pollution and temperature on COPD. COPD. 2016;13(3):372–379.
  • Heinrich J, Schikowski T. COPD patients as vulnerable subpopulation for exposure to ambient air pollution. Curr Environ Health Rep. 2018;5(1):70–76.
  • Schraufnagel DE, Balmes JR, Cowl CT, et al. Air pollution and noncommunicable diseases: a review by the forum of international respiratory societies’ environmental committee, part 2: air pollution and organ systems. Chest. 2019;155(2):417–426.
  • Schraufnagel DE, Balmes JR, Cowl CT, et al. Air pollution and noncommunicable diseases: a review by the forum of international respiratory societies’ environmental committee, part 1: the damaging effects of air pollution. Chest. 2019;155(2):409–416.
  • Collaco JM, Blackman SM, McGready J, et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157(5):802–7 e1–3.
  • Margolis HG, Mann JK, Lurmann FW, et al. Altered pulmonary function in children with asthma associated with highway traffic near residence. Int J Environ Health Res. 2009;19(2):139–155.
  • O’Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics. 2003;111(4 Pt 1):e333–9.
  • Auger KA, Kahn RS, Simmons JM, et al. Using address information to identify hardships reported by families of children hospitalized with asthma. Acad Pediatr. 2017;17(1):79–87.
  • Feng X, Astell-Burt T. Is neighborhood green space protective against associations between child asthma, neighborhood traffic volume and perceived lack of area safety? Multilevel analysis of 4447 Australian children. Int J Environ Res Public Health. 2017;14(5). DOI:10.3390/ijerph14050543
  • Douglas JA, Archer RS, Alexander SE. Ecological determinants of respiratory health: examining associations between asthma emergency department visits, diesel particulate matter, and public parks and open space in Los Angeles, California. Prev Med Rep. 2019;14:100855.
  • Tischer C, Gascon M, Fernandez-Somoano A, et al. Urban green and grey space in relation to respiratory health in children. Eur Respir J. 2017;49(6). DOI:10.1183/13993003.02112-2015
  • Gernes R, Brokamp C, Rice GE, et al. Using high-resolution residential greenspace measures in an urban environment to assess risks of allergy outcomes in children. Sci Total Environ. 2019;668:760–767.
  • Hsieh CJ, Yu PY, Tai CJ, et al. Association between the first occurrence of asthma and residential greenness in children and teenagers in Taiwan. Int J Environ Res Public Health. 2019;16(12). DOI:10.3390/ijerph16122076
  • Roberts JM, Wilcox PG, Quon BS. Evaluating adult cystic fibrosis care in BC: disparities in access to a multidisciplinary treatment centre. Can Respir J. 2016;2016:8901756.
  • Vandenbranden SL, McMullen A, Schechter MS, et al. Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol. 2012;47(2):135–143.
  • Szczesniak RD, Li D, Su W, et al. Phenotypes of rapid cystic fibrosis lung disease progression during adolescence and young adulthood. Am J Respir Crit Care Med. 2017;196:471–478.
  • Beck AF, Huang B, Chundur R, et al. Housing code violation density associated with emergency department and hospital use by children with asthma. Health Aff (Millwood). 2014;33(11):1993–2002.
  • Brugha R, Edmondson C, Davies JC. Outdoor air pollution and cystic fibrosis. Paediatr Respir Rev. 2018;28:80–86.
  • Psoter KJ, De Roos AJ, Mayer JD, et al. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. Ann Am Thorac Soc. 2015;12(3):385–391.
  • Qu F, Qin XQ, Cui YR, et al. Ozone stress down-regulates the expression of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial cells. Chem Biol Interact. 2009;179(2–3):219–226.
  • Ahmad S, Nichols DP, Strand M, et al. SERCA2 regulates non-CF and CF airway epithelial cell response to ozone. PloS One. 2011;6(11):e27451.
  • Kunzi L, Krapf M, Daher N, et al. Toxicity of aged gasoline exhaust particles to normal and diseased airway epithelia. Sci Rep. 2015;5:11801.
  • Psoter KJ, De Roos AJ, Wakefield J, et al. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis. BMC Pulm Med. 2017;17(1):106.
  • Collaco JM, McGready J, Green DM, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PloS One. 2011;6(11):e27784.
  • Goeminne PC, Kicinski M, Vermeulen F, et al. Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest. 2013;143(4):946–954.
  • Farhat SCL, Almeida MB, Silva-Filho L, et al. Ozone is associated with an increased risk of respiratory exacerbations in patients with cystic fibrosis. Chest. 2013;144(4):1186–1192.
  • Goss CH, Newsom SA, Schildcrout JS, et al. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004;169(7):816–821.
  • Zheng XY, Ding H, Jiang LN, et al. Association between air pollutants and asthma emergency room visits and hospital admissions in time series studies: a systematic review and meta-analysis. PLoS One. 2015;10(9):e0138146.
  • Jassal MS, Yu AM, Bhatia R, et al. Effect of residential proximity to major roadways on cystic fibrosis exacerbations. Int J Environ Health Res. 2013;23(2):119–131.
  • Collaco JM, Morrow CB, Green DM, et al. Environmental allergies and respiratory morbidities in cystic fibrosis. PediatrPulmonol. 2013;48(9):857–864.
  • Brakema EA, Tabyshova A, Kasteleyn MJ, et al. High COPD prevalence at high altitude: does household air pollution play a role? Eur Respir J. 2019;53(2):1801193.
  • Falk B, Nini A, Zigel L, et al. Effect of low altitude at the Dead Sea on exercise capacity and cardiopulmonary response to exercise in cystic fibrosis patients with moderate to severe lung disease. Pediatr Pulmonol. 2006;41(3):234–241.
  • Ryujin DT, Mannebach SC, Samuelson WM, et al. Oxygen saturation in adult cystic fibrosis patients during exercise at high altitude. Pediatr Pulmonol. 2001;32(6):437–441.
  • Oades PJ, Buchdahl RM, Bush A. Prediction of hypoxaemia at high altitude in children with cystic fibrosis. BMJ. 1994;308(6920):15–18.
  • Oates GR, Harris WT, Rowe SM, et al. Area deprivation as a risk factor for methicillin-resistant staphylococcus aureus infection in pediatric cystic fibrosis. Pediatr Infect Dis J. 2019;38(11):e285–e9.
  • Collaco JM, Raraigh KS, Appel LJ, et al. Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis. J Cyst Fibros. 2016;15:794–801.
  • Collaco JM, Appel LJ, McGready J, et al. The relationship of lung function with ambient temperature. PloS One. 2018;13(1):e0191409.
  • Psoter KJ, Rosenfeld M, De Roos AJ, et al. Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis. Am J Epidemiol. 2014;179(12):1503–1513.
  • Ramsay KA, Butler CA, Paynter S, et al. Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. J Clin Microbiol. 2013;51(12):3975–3980.
  • Prevots DR, Adjemian J, Fernandez AG, et al. Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population. Ann Am Thorac Soc. 2014;11(7):1032–1038.
  • Psoter KJ, De Roos AJ, Wakefield J, et al. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect. 2013;19(11):E483–9.
  • Johansen HK, Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax. 1992;47(2):109–111.
  • Farrell PM, Shen G, Splaingard M, et al. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics. 1997;100(5):E2.
  • Psoter KJ, De Roos AJ, Wakefield J, et al. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. BMC Infect Dis. 2017;17(1):411.
  • Flight WG, Bright-Thomas RJ, Sarran C, et al. The effect of the weather on pulmonary exacerbations and viral infections among adults with cystic fibrosis. Int J Biometeorol. 2014;58(9):1845–1851.
  • Miro-Canis S, Capilla-Rubio S, Marzo-Checa L, et al. Multiplex PCR reveals that viruses are more frequent than bacteria in children with cystic fibrosis. J Clin Virol. 2017;86:1–4.
  • Qvist T, Schluter DK, Rajabzadeh V, et al. Seasonal fluctuation of lung function in cystic fibrosis: a national register-based study in two northern European populations. J Cyst Fibros. 2018. DOI:10.1016/j.jcf.2018.10.006.
  • Ooi CY, Jeyaruban C, Lau J, et al. High ambient temperature and risk of intestinal obstruction in cystic fibrosis. J Paediatr Child Health. 2016;52(4):430–435.
  • Lansing AH, McDonald C, Patel RA, et al. Vitamin D deficiency in pediatric patients with cystic fibrosis: associated risk factors in the northern United States. South Med J. 2015;108(3):164–169.
  • Oliveira MS, Matsunaga NY, Rodrigues MLE, et al. Lung disease and vitamin D levels in cystic fibrosis infants and preschoolers. Pediatr Pulmonol. 2019;54(5):563–574.
  • Bouso JM, Burns JJ, Amin R, et al. Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis. Pediatr Pulmonol. 2017;52(3):324–330.
  • Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26(2):81–88.
  • Simmonds EJ, Littlewood JM, Hopwood V, et al. Aspergillus fumigatus colonisation and population density of place of residence in cystic fibrosis. Arch Dis Child. 1994;70(2):139–140.
  • Roca-Barcelo A, Douglas P, Fecht D, et al. Risk of respiratory hospital admission associated with modelled concentrations of Aspergillus fumigatus from composting facilities in England. Environ Res. 2019;2019:108949.
  • Klepeis NE, Nelson WC, Ott WR, et al. The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol. 2001;11(3):231–252.
  • Hansel NN, Breysse PN, McCormack MC, et al. A longitudinal study of indoor nitrogen dioxide levels and respiratory symptoms in inner-city children with asthma. Environ Health Perspect. 2008;116(10):1428–1432.
  • Matsui EC. Environmental exposures and asthma morbidity in children living in urban neighborhoods. Allergy. 2014;69(5):553–558.
  • McCormack MC, Breysse PN, Matsui EC, et al. In-home particle concentrations and childhood asthma morbidity. Environ Health Perspect. 2009;117(2):294–298.
  • Britto MT, Garrett JM, Dugliss MA, et al. Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study. Pediatrics. 1998;101(2):250–256.
  • Verma A, Clough D, McKenna D, et al. Smoking and cystic fibrosis. J R Soc Med. 2001;94(Suppl 40):29–34.
  • Stern RC, Byard PJ, Tomashefski JF Jr., et al. Recreational use of psychoactive drugs by patients with cystic fibrosis. J Pediatr. 1987;111(2):293–299.
  • Collaco JM, Vanscoy L, Bremer L, et al. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA. 2008;299(4):417–424.
  • Ong T, Schechter M, Yang J, et al. Socioeconomic status, smoke exposure, and health outcomes in young children with cystic fibrosis. Pediatrics. 2017;139(2):e20162730.
  • Kovesi T, Corey M, Levison H. Passive smoking and lung function in cystic fibrosis. AmRevRespirDis. 1993;148(5):1266–1271.
  • Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med. 1990;323(12):782–788.
  • Oates GR, Baker E, Rowe SM, et al. Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis. J Cyst Fibros. 2020. DOI:10.1016/j.jcf.2020.02.004.
  • Cantin AM. Cystic fibrosis transmembrane conductance regulator. Implications in cystic fibrosis and chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(Suppl 2):S150–5.
  • Ni I, Ji C, Vij N. Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts. PloS One. 2015;10(3):e0121200.
  • Kopp BT, Thompson R, Kim J, et al. Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis. Thorax. 2019;74(3):237–246.
  • Kopp BT, Sarzynski L, Khalfoun S, et al. Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis. Pediatr Pulmonol. 2015;50(1):25–34.
  • Kopp BT, Ortega-Garcia JA, Sadreameli SC, et al. The impact of secondhand smoke exposure on children with cystic fibrosis: a review. Int J Environ Res Public Health. 2016;13(10). DOI:10.3390/ijerph13101003.
  • Reid LEM, Pretsch U, Jones MC, et al. The acute medical unit model: a characterisation based upon the National Health Service in Scotland. PLoS One. 2018;13(10):e0204010.
  • Smyth A, O’Hea U, Williams G, et al. Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child. 1994;71(4):353–354.
  • Rosenfeld M, Emerson J, McNamara S, et al. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. PediatrPulmonol. 2010;45(9):934–944.
  • Sanders DB, Emerson J, Ren CL, et al. Early childhood risk factors for decreased FEV1 at age six to seven years in young children with cystic fibrosis. Ann Am Thorac Soc. 2015;12(8):1170–1176.
  • Rocchi S, Richaud-Thiriez B, Barrera C, et al. Evaluation of mold exposure in cystic fibrosis patients’ dwellings and allergic bronchopulmonary risk. J Cyst Fibros. 2015;14(2):242–247.
  • Thronicke A, Heger N, Antweiler E, et al. Allergic bronchopulmonary aspergillosis is associated with pet ownership in cystic fibrosis. Pediatr Allergy Immunol. 2016;27(6):597–603.
  • Morrow CB, Raraigh KS, Green DM, et al. Cat and dog exposure and respiratory morbidities in cystic fibrosis. J Pediatr. 2014;165(4):830–835.
  • Lavie M, Shemer O, Sarouk I, et al. Several siblings with cystic fibrosis as a risk factor for poor outcome. Respir Med. 2015;109(1):74–78.
  • Katz SL, Strug LJ, Coates AL, et al. Disease severity in siblings with cystic fibrosis. Pediatr Pulmonol. 2004;37(5):407–412.
  • Slieker MG, van den Berg JM, Kouwenberg J, et al. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study. Pediatr Pulmonol. 2010;45(6):601–607.
  • Jessup M, Smyth W, Abernethy G, et al. Family-centred care for families living with cystic fibrosis in a rural setting: a qualitative study. J Clin Nurs. 2018;27(3–4):e590–e9.
  • Weber HC, Robinson PF, Saxby N, et al. Do children with cystic fibrosis receiving outreach care have poorer clinical outcomes than those treated at a specialist cystic fibrosis centre? Aust J Rural Health. 2017;25(1):34–41.
  • Johnson B, Ngueyep R, Schechter MS, et al. Does distance to a cystic fibrosis center impact health outcomes? Pediatr Pulmonol. 2018;53(3):284–292.
  • Schechter MS. Reevaluating approaches to cystic fibrosis pulmonary exacerbations. Pediatr Pulmonol. 2018;53(S3):S51–S63.
  • Walicka-Serzysko K, Peckova M, Noordhoek JJ, et al. Insights into the cystic fibrosis care in Eastern Europe: results of survey. J Cyst Fibros. 2018;17(4):475–477.
  • Schwarz C, Hartl D. Cystic fibrosis in Europe: patients live longer but are we ready? Eur Respir J. 2015;46(1):11–12.
  • Burgel PR, Bellis G, Olesen HV, et al. Future trends in cystic fibrosis demography in 34 European countries. Eur Respir J. 2015;46(1):133–141.
  • Brulle RJ, Pellow DN. Environmental justice: human health and environmental inequalities. Annu Rev Public Health. 2006;27:103–124. Epub 2006/ 03/15.
  • Oates GR, Schechter MS. Socioeconomic status and health outcomes: cystic fibrosis as a model. Expert Rev Respir Med. 2016;10(9):967–977.
  • Taylor-Robinson DC, Smyth R, Diggle PJ, et al. A longitudinal study of the impact of social deprivation and disease severity on employment status in the UK cystic fibrosis population. PLoS One. 2013;8(8):e73322.
  • Curtis JR, Burke W, Kassner AW, et al. Absence of health insurance is associated with decreased life expectancy in patients with cystic fibrosis. Am J Respir Crit Care Med. 1997;155(6):1921–1924.
  • Schechter MS, Margolis PA. Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr. 1998;132(2):260–264.
  • Schechter MS, Shelton BJ, Margolis PA, et al. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163(6):1331–1337.
  • Schechter MS, McColley SA, Silva S, et al. Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr. 2009;155(5):634–639.
  • Miller KA, Siscovick DS, Sheppard L, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356(5):447–458.
  • Krieger N, Waterman P, Chen JT, et al. Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas–the public health disparities geocoding project. Am J Public Health. 2002;92(7):1100–1102.
  • Jerrett M, Burnett RT, Ma R, et al. Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology. 2005;16(6):727–736.
  • Zandbergen PA, Chakraborty J. Improving environmental exposure analysis using cumulative distribution functions and individual geocoding. Int J Health Geogr. 2006;5:23.
  • Zandbergen PA. Influence of geocoding quality on environmental exposure assessment of children living near high traffic roads. BMC Public Health. 2007;7:37.
  • Zandbergen PA. Ensuring confidentiality of geocoded health data: assessing geographic masking strategies for individual-level data. Adv Med. 2014;2014:567049.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.